GET THE APP

Immunome Research

Immunome Research
Open Access

ISSN: 1745-7580

+44-20-4587-4809

Opinion - (2022)Volume 18, Issue 4

Remark to Immunome Research

Anne Borba*
 
*Correspondence: Anne Borba, Department of Medicine, University of Milan, Milan, Italy, Email:

Author info »

Description

The Immunome Research Journal is an open access, peerreviewed journal that accepts original research articles and reviews on the latest breakthroughs and discoveries in immunology, preclinical and clinical medicine, and allied disciplines. The journal's ISSN is 1745-7580. Journals flourish by providing the most comprehensive source of discovery and accurate details on findings in all areas of the field, as well as recent breakthroughs, in the form of original papers, analysis, articles, case reports, brief messages, and other formats, all of which are freely available online to researchers all over the world, with no restrictions or subscriptions.

All published articles in this journal are indexed and abstracted by Euro Pub, Geneva Foundation for Medical Research, University Grants Commission, MIAR, EBSCO A-Z, Hamdard University, RefSeek, Scimago, and Open J Gate, and all published articles are permanently archived. All published articles are given a Digital Object Identifier (DOI).

IMR is especially interested in publications that detail significant advancements in medical research, disease treatment, and immunology. Manuscripts describing how medical science has altered healthcare, extending and improving the quality of life for millions, are invited in this regard.

We recognise the time and work that goes into writing a good peer review, and we respect the contributions of reviewers who donate their time and expertise to provide useful resources with critical feedback that ensures the high quality of research published in each issue of the journal. We thank our peer reviewers for taking the time and effort to provide thoughtful feedback, and we endeavour to express our gratitude to them. Every year, we send letters thanking our top reviewers for their contributions.

Authors can use the online tracking system to submit papers and track their progress toward publication. As every report that is to be made public must be submitted within 45 days of receipt. Various processes, such as quality control, peer review, and paper preparation, take between 4 and 5 weeks to complete. The performance reviews and peer reviews take 14 days to complete, and the submission deadline is only seven days after the reviewers and editors accept.

Volume 17 and Issue 6 of the IMR will be released. Peer review is a system for evaluating a manuscript's quality before it is published. Qualified scholars in the appropriate study area evaluate submitted manuscripts for originality, validity, and significance to assist editors in deciding whether or not to publish the manuscript.

Additionally, writers of articles published in this journal are the copyright proprietors of their articles and have allowed any third party the right to use, reproduce, or disseminate their articles in advance and in perpetuity.

I'd want to take this occasion to thank the Longdom group of publishers for their efforts in bringing the journal's on-line publication to a global audience. I feel, this journal will serve better to the scientific community. To ensure the journal's future success, I would want to encourage our scientific community to contribute original research.

I'd like to thank all of the writers, reviewers, and other supporter groups for their contributions to the final editing of the published articles, as well as the editorial assistant's help in resolving IMR concerns in a timely manner. I owe them a debt of gratitude for motivating me to appreciate the work and progress of other organisations that contribute to the successful publication of articles.

Author Info

Anne Borba*
 
Department of Medicine, University of Milan, Milan, Italy
 

Citation: Borba A (2022) Remark to Immunome Research. Immunome Res. 18: 216

Received: 29-Nov-2022, Manuscript No. IMR-22-21459 ; Editor assigned: 02-Dec-2022, Pre QC No. IMR-22-21459 (PQ); Reviewed: 16-Dec-2022, QC No. IMR-22-21459 ; Revised: 21-Dec-2022, Manuscript No. IMR-22-21459 (R); Published: 30-Dec-2022 , DOI: 10.35248/1745-7580.22.18.216

Copyright: ©2022 Borba A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top